Wei JT - Search Results

1

Timing of Adverse Prostate Cancer Reclassification on First Surveillance Biopsy: Results from the Canary Prostate Cancer Active Surveillance Study.

Macleod LC, Ellis WJ, Newcomb LF, Zheng Y, Brooks JD, Carroll PR, Gleave ME, Lance RS, Nelson PS, Thompson IM Jr, Wagner AA, Wei JT, Lin DW. Macleod LC, et al. Among authors: wei jt. J Urol. 2017 Apr;197(4):1026-1033. doi: 10.1016/j.juro.2016.10.090. Epub 2016 Nov 1. J Urol. 2017. PMID: 27810448 Free PMC article.

2

The influence of prostate size on cancer detection.

Uzzo RG, Wei JT, Waldbaum RS, Perlmutter AP, Byrne JC, Vaughan ED Jr. Uzzo RG, et al. Among authors: wei jt. Urology. 1995 Dec;46(6):831-6. doi: 10.1016/s0090-4295(99)80353-7. Urology. 1995. PMID: 7502425

3

Androgen deprivation therapy for prostate cancer results in significant loss of bone density.

Wei JT, Gross M, Jaffe CA, Gravlin K, Lahaie M, Faerber GJ, Cooney KA. Wei JT, et al. Urology. 1999 Oct;54(4):607-11. doi: 10.1016/s0090-4295(99)00301-5. Urology. 1999. PMID: 10510915 Clinical Trial.

4

Bladder neck-sparing modification of radical prostatectomy adversely affects surgical margins in pathologic T3a prostate cancer.

Marcovich R, Wojno KJ, Wei JT, Rubin MA, Montie JE, Sanda MG. Marcovich R, et al. Among authors: wei jt. Urology. 2000 Jun;55(6):904-8. doi: 10.1016/s0090-4295(00)00451-9. Urology. 2000. PMID: 10840106

5

Prospective assessment of patient reported urinary continence after radical prostatectomy.

Wei JT, Dunn RL, Marcovich R, Montie JE, Sanda MG. Wei JT, et al. J Urol. 2000 Sep;164(3 Pt 1):744-8. doi: 10.1097/00005392-200009010-00029. J Urol. 2000. PMID: 10953138

6

Whole mounted radical prostatectomy specimens do not increase detection of adverse pathological features.

Hollenbeck BK, Bassily N, Wei JT, Montie JE, Hayasaka S, Taylor JM, Rubin MA. Hollenbeck BK, et al. Among authors: wei jt. J Urol. 2000 Nov;164(5):1583-6. J Urol. 2000. PMID: 11025709

7

Benign prostatic glands at surgical margins of radical prostatectomy specimens: frequency and associated risk factors.

Shah R, Bassily N, Wei J, Mucci NR, Montie JE, Sanda MG, Rubin MA. Shah R, et al. Urology. 2000 Nov 1;56(5):721-5. doi: 10.1016/s0090-4295(00)00775-5. Urology. 2000. PMID: 11068287

8

Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer.

Wei JT, Dunn RL, Litwin MS, Sandler HM, Sanda MG. Wei JT, et al. Urology. 2000 Dec 20;56(6):899-905. doi: 10.1016/s0090-4295(00)00858-x. Urology. 2000. PMID: 11113727

9

Age-specific distribution of serum prostate-specific antigen in a community-based study of African-American men.

Cooney KA, Strawderman MS, Wojno KJ, Doerr KM, Taylor A, Alcser KH, Heeringa SG, Taylor JM, Wei JT, Montie JE, Schottenfeld D. Cooney KA, et al. Among authors: wei jt. Urology. 2001 Jan;57(1):91-6. doi: 10.1016/s0090-4295(00)00873-6. Urology. 2001. PMID: 11164150 Review.

10

The natural history of lower urinary tract symptoms in black American men: relationships with aging, prostate size, flow rate and bothersomeness.

Wei JT, Schottenfeld D, Cooper K, Taylor JM, Faerber GJ, Velarde MA, Bree R, Montie JE, Cooney KA. Wei JT, et al. J Urol. 2001 May;165(5):1521-5. J Urol. 2001. PMID: 11342910

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

398 results

Search Page

Filters